Distinguishing Serotonin Syndrome Hyperreflexia in MS Patients
In MS patients, look for clonus (spontaneous, ocular, or inducible) combined with hyperreflexia—this combination is highly specific for serotonin syndrome and does not occur in MS alone. The key is that MS causes hyperreflexia without clonus, while serotonin syndrome characteristically produces both hyperreflexia AND clonus together 1.
Critical Distinguishing Features
The Clonus-Hyperreflexia Pattern
The most diagnostically useful finding is clonus, which occurs in serotonin syndrome but not in MS-related spasticity 1. According to the modified Dunkley criteria, serotonin syndrome can be diagnosed in patients on serotonergic drugs within the last 5 weeks if they have:
- Tremor AND hyperreflexia together
- Spontaneous clonus (without stimulation)
- Inducible clonus (elicited by rapid dorsiflexion) plus agitation or diaphoresis
- Ocular clonus (horizontal eye movement abnormalities) plus agitation or diaphoresis 1
Distribution Pattern Matters
Serotonin syndrome produces increased muscle tone and hyperreflexia that is MORE PRONOUNCED in the lower extremities than upper extremities 1. This asymmetric distribution can help differentiate it from MS, where spasticity patterns follow the anatomical distribution of demyelinating lesions.
Essential Clinical Context
Temporal Relationship
Serotonin syndrome typically develops within 6-24 hours of starting a serotonergic medication, increasing the dose, or adding a second serotonergic agent 1. This rapid onset contrasts sharply with MS exacerbations, which evolve over days to weeks. If hyperreflexia worsens acutely after medication changes, suspect serotonin syndrome.
The Complete Clinical Triad
Don't rely on neuromuscular findings alone. Serotonin syndrome requires the presence of the clinical triad: mental status changes, autonomic hyperactivity, and neuromuscular abnormalities 1. Look for:
- Mental status changes: Agitated delirium, confusion, anxiety (not the cognitive changes of MS)
- Autonomic hyperactivity: Tachycardia, hypertension, diaphoresis, hyperthermia (temperature ≤41.1°C), mydriasis 1
- Neuromuscular findings: The hyperreflexia/clonus combination, tremor, muscle rigidity 1
Additional Differentiating Signs
- Myoclonus occurs in 57% of serotonin syndrome cases and is highly suggestive 1
- Hyperactive bowel sounds and diarrhea occur in serotonin syndrome, not MS 1
- Sialorrhea (excessive salivation) is seen in serotonin syndrome 1
Practical Examination Approach
- Check for clonus systematically: Test for spontaneous clonus at rest, then inducible clonus with rapid dorsiflexion of the ankle, and ocular clonus with lateral gaze
- Compare upper vs. lower extremity findings: Greater lower extremity involvement suggests serotonin syndrome
- Assess vital signs: Tachycardia, hypertension, and fever point to serotonin syndrome
- Examine pupils: Mydriasis occurs in serotonin syndrome, not MS 1
- Check skin: Diaphoresis is prominent in serotonin syndrome 1
Common Pitfalls
Hypertonicity can mask hyperreflexia in severe serotonin syndrome 1. If muscle rigidity is severe, reflexes may be difficult to elicit, but clonus should still be present.
The Hunter Serotonin Toxicity Criteria have 84% sensitivity and 97% specificity 1, making them more reliable than older Sternbach criteria. However, research suggests diagnostic criteria don't always agree 2, so clinical judgment incorporating medication history and temporal relationship remains essential.
Mortality Considerations
This distinction is life-critical: serotonin syndrome carries an 11% mortality rate with severe cases progressing to rhabdomyolysis, metabolic acidosis, renal failure, seizures, and disseminated intravascular coagulation 1. Immediate discontinuation of serotonergic agents and supportive care are required 1.